Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Novel drug for treating eye disease

A drug and functional technology, applied in the field of medicine, can solve the problem of slow recovery of drugs, and achieve the effects of treating myopia, correcting vision, and improving human immunity.

Pending Publication Date: 2020-06-30
梅连武
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] Aiming at the deficiencies of the prior art, the present invention provides a novel drug with the function of treating eye diseases, which solves the problem of slow recovery of the existing drugs for treating eye diseases

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel drug for treating eye disease
  • Novel drug for treating eye disease
  • Novel drug for treating eye disease

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029] Embodiment 1. The parts by weight of each raw material are aspartic acid 0.001, threonine 0.001, serine 0.001, cystine 0.001, valine 0.001, methionine 0.001, isoleucine 0.001, leucine 0.001 , tyrosine 0.001, glutamic acid 0.001, glycine 0.001, alanine 0.001, lysine 0.001, taurine 0.001, carnosine 0.001, nucleotide 0.001, polypeptide 0.001, vitamin B1 0.001, vitamin B6 0.001, vitamin B12 0.001, calcium 0.0001, iodine 0.0001, magnesium 0.0001.

[0030] A preparation method of a novel drug with the function of treating eye diseases, comprising the following steps:

[0031] Each raw material of S1 is weighed according to the ratio of parts by weight, and respectively aspartic acid, threonine, serine, cystine, valine, methionine, isoleucine, leucine, tyrosine, glutamine Acid, glycine, alanine, lysine, taurine, carnosine, nucleotide, polypeptide, vitamin B1, vitamin B6, vitamin B12, calcium, iodine, magnesium are ground to 100 mesh, and the powder after grinding is fully sti...

Embodiment 2

[0056] Embodiment 2, the parts by weight of each raw material are aspartic acid 0.0025, threonine 0.0025, serine 0.0025, cystine 0.0025, valine 0.0025, methionine 0.0025, isoleucine 0.0025, leucine 0.0025 , Tyrosine 0.0025, Glutamic Acid 0.0025, Glycine 0.0025, Alanine 0.0025, Lysine 0.0025, Taurine 0.0025, Carnosine 0.0025, Nucleotide 0.0025, Peptide 0.0025, Vitamin B1 0.0025, Vitamin B6 0.0025, Vitamin B120 .0025, Calcium 0.0002, Iodine 0.0002, Magnesium 0.0002.

Embodiment 3

[0057] Embodiment three, the parts by weight of each raw material are aspartic acid 0.005, threonine 0.005, serine 0.005, cystine 0.005, valine 0.005, methionine 0.005, isoleucine 0.005, leucine 0.005 , tyrosine 0.005, glutamic acid 0.005, glycine 0.005, alanine 0.005, lysine 0.005, taurine 0.005, carnosine 0.005, nucleotide 0.005, polypeptide 0.005, vitamin B1 0.005, vitamin B6 0.005, vitamin B12 0.005, calcium 0.0004, iodine 0.0004, magnesium 0.0004.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a novel drug for treating eye disease. The drug is prepared from the following raw materials in parts by weight of 0.001-0.1 of aspartic acid, 0.001-0.1 of threonine, 0.001-0.1of serine, 0.001-0.1 of cystine, 0.001-0.1 of valine, 0.001-0.1 of methionine, 0.001-0.1 of isoleucine, and 0.001-0.1 of leucine. The invention relates to the technical field of medicine. The novel drug for treating eye diseases has the effects of promoting metabolism of the eye tissue, accelerating scar healing, absorbing inflammation exudation, and promoting regeneration of skin tissues on thecornea and the like, the ciliary nutrition conditions can be rapidly improved, the ciliary muscle spasm can be released, reflux of liquid from inside of eyes to outside is accelerated, the effect is quick and obvious, and the effects of relieving internal eye high pressure, rapidly restraining visual fatigue, quickly correcting vision and binocular vision dysfunction can be achieved, and the effects of rapidly improving human immunity, treating both symptoms and root causes, being difficult to relapse, free of toxic and side effects and the like can be realized; and the novel drug can be usedfor effectively treating myopia, presbyopia, visual fatigue and various chronic ophthalmic diseases.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to a novel drug capable of treating eye diseases. Background technique [0002] With the advancement of science and technology, the rapid development of productivity, the modernization of lifestyles and the popularization of TVs, computers, mobile phones, game consoles and other video game devices, although life has brought us great convenience, these electronic devices have brought great convenience to us. We have caused great harm. According to the survey, the myopia rate of primary school students in China has reached 60%, that of junior high school students has reached 70%, that of high school students has reached 80%, and that of college students has reached 90%. %, in China, the proportion of 50-year-old aging has reached 80%, and the visual fatigue of workers who use computers for a long time has exceeded 85%. The number of myopia in China has exceeded 400 million, and the n...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K38/05A61P27/02A61P27/10B01F7/00B01F7/18B01F15/02A61K31/198A61K31/185A61K38/02A61K31/7052A61K31/51A61K31/4415A61K31/714A61K33/06A61K33/18
CPCA61K38/02A61K31/198A61K31/185A61K38/05A61K31/7052A61K31/51A61K31/4415A61K31/714A61K33/06A61K33/18A61K9/0048A61P27/02A61P27/10B01F27/191B01F27/90B01F35/714B01F2101/22A61K2300/00
Inventor 梅连武
Owner 梅连武
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com